On Tuesday, Mind Medicine Inc (NASDAQ: MNMD) was 1.02% up from the session before settling in for the closing price of $9.78. A 52-week range for MNMD has been $2.41 – $12.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 35.25%. With a float of $26.94 million, this company’s outstanding shares have now reached $41.10 million.
Let’s look at the performance matrix of the company that is accounted for 57 employees.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mind Medicine Inc stocks. The insider ownership of Mind Medicine Inc is 4.34%, while institutional ownership is 61.39%. The most recent insider transaction that took place on Mar 25 ’24, was worth 156,930. In this transaction Chief Executive Officer of this company sold 16,519 shares at a rate of $9.50, taking the stock ownership to the 580,202 shares. Before that another transaction happened on Mar 25 ’24, when Company’s Chief Medical Officer sold 6,578 for $9.50, making the entire transaction worth $62,491. This insider now owns 358,452 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 9.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 35.25% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
You can see what Mind Medicine Inc (MNMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.45, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Mind Medicine Inc (NASDAQ: MNMD) saw its 5-day average volume 1.55 million, a negative change from its year-to-date volume of 1.98 million. As of the previous 9 days, the stock’s Stochastic %D was 17.19%. Additionally, its Average True Range was 1.00.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 75.65%, which indicates a significant increase from 27.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.57% in the past 14 days, which was lower than the 108.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.66, while its 200-day Moving Average is $4.62. Nevertheless, the first resistance level for the watch stands at $10.17 in the near term. At $10.46, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.90. If the price goes on to break the first support level at $9.44, it is likely to go to the next support level at $9.00. The third support level lies at $8.71 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
There are 70,268K outstanding shares of the company, which has a market capitalization of 278.22 million. As of now, sales total 0 K while income totals -95,730 K. Its latest quarter income was 0 K while its last quarter net income were -23,860 K.
